Skip to main content
Article
Treatment options for acute myocardial infarction complicated by cardiogenic shock
Quantitative Health Sciences Publications and Presentations
  • Harold L. Dauerman, University of Massachusetts Medical School
  • Robert J. Goldberg, University of Massachusetts Medical School
  • Joel M. Gore, University of Massachusetts Medical School
UMMS Affiliation
Department of Medicine, Division of Cardiovascular Medicine
Publication Date
2-15-2001
Document Type
Article
Subjects
Balloon Dilatation; Coronary Artery Bypass; Humans; Intra-Aortic Balloon Pumping; Myocardial Infarction; Myocardial Reperfusion; Prognosis; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Thrombolytic Therapy
Abstract
Hospital survival of patients with acute myocardial infarction complicated by cardiogenic shock has improved during recent years. Before the 1990s, emphasis on a medical and supportive approach to treatment of these high-risk patients (including thrombolytic therapy) was not clearly associated with improving outcomes. However, in the past decade, the interventional approach to treatment of acute myocardial infarction complicated by cardiogenic shock (mainly acute infarct angioplasty) has led to an improving prognosis across a broad spectrum of patients with cardiogenic shock.
Source
Cardiol Rev. 2000 Jul-Aug;8(4):207-15.
PubMed ID
11174897
Related Resources
Link to Article in PubMed
Citation Information
Harold L. Dauerman, Robert J. Goldberg and Joel M. Gore. "Treatment options for acute myocardial infarction complicated by cardiogenic shock" Vol. 8 Iss. 4 (2001) ISSN: 1061-5377 (Linking)
Available at: http://works.bepress.com/robert_goldberg/234/